Insiders · Profile

EGLINTON MANNER CARRIE

President & CEO at ORASURE TECHNOLOGIES · Director at REPLIGEN · SVP, Advanced Diagnostics at Quest Diagnostics. Filing since 27 Apr 2020. CIK 0001696776

Company
Date
Role
Action
Shares
Amount
Of holding
20 Mar 2026
President & CEO
Bought on a plan
32,300
$94.60K
1.5%
13 Mar 2026
President & CEO
Bought on a plan
22,022
$66.03K
1.0%
28 Feb 2025
President & CEO
Bought
28,670
$100.03K
2.3%
27 Feb 2025
President & CEO
Bought
78,625
$247.38K
6.7%
16 Mar 2022
Director
Bought
625
$109.39K
42.2%
27 Apr 2020
SVP, Advanced Diagnostics
Sold, plan not stated
5,000
$555.08K
18.3%
6 decisions on file.